Amino acids at positions 3, 168, and 169 are associated with the ability of Nef proteins from HIV-1 CRF01_AE to downmodulate CD4

Journal of Medical Virology
Wen-Dong KuangJian-Hua Wang

Abstract

Several HIV-1 subtypes are co-circulating among various high-risk groups in China, and an increasing prevalence of CRF01_AE was observed among MSM (men who have sex with men) within recent years. Patients infected with CRF01_AE may experience a more rapid disease progression than patients infected with non-CRF01_AE; however, the underlying mechanisms remains elusive. HIV-1 Nef is a multifunctional protein and plays critical roles in viral pathogenesis. Nef downregulates CD4 and human leukocyte antigen (HLA) to promote viral transmission and escape from the host immune response. In this study, we investigated the CD4 downmodulation activity of Nef proteins isolated from HIV-1 CRF01_AE and analyzed a potential relationship of Nef's capacity to downregulate CD4 with disease progression. We found that the majority of these Nefs from HIV-1 CRF01_AE efficiently downregulated CD4; Nefs with weaker CD4 downmodulation activity tended to be associated with higher CD4 levels and lower viral loads. Further elucidation revealed that amino acid residues at positions 3, 168, and 169 of CRF01_AE Nefs were associated with the capacity to downregulate CD4. Our data suggest that the capacity of Nef-mediated CD4 downregulation is not the only dete...Continue Reading

References

Nov 21, 1997·Computer Applications in the Biosciences : CABIOS·Z Yang
Sep 16, 1998·Proceedings of the National Academy of Sciences of the United States of America·H M CraigJ C Guatelli
Apr 4, 2001·The EMBO Journal·T SwigutJ Skowronski
Jul 21, 2001·EMBO Reports·M GeyerB M Peterlin
Oct 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·P Stumptner-CuveletteP Benaroch
Feb 4, 2005·Molecular Biology and Evolution·Ziheng YangRasmus Nielsen
Jun 9, 2006·Microbiology and Molecular Biology Reviews : MMBR·Jeremiah F Roeth, Kathleen L Collins
Nov 23, 2007·Journal of Virology·O Wolf LindwasserJuan S Bonifacino
Apr 29, 2008·Cellular and Molecular Life Sciences : CMLS·F KirchhoffJ Münch
May 14, 2008·Current HIV Research·Kevin K Ariën, Bruno Verhasselt
Sep 24, 2008·Retrovirology·John L Foster, J Victor Garcia
Mar 6, 2010·Current HIV Research·Autumn RuizEdward B Stephens
Dec 24, 2010·Retrovirology·Mathieu DubéÉric A Cohen
Feb 22, 2011·Journal of Neuroimmune Pharmacology : the Official Journal of the Society on NeuroImmune Pharmacology·John L FosterJ Victor Garcia
Apr 25, 2012·Current HIV Research·Fabien P BlanchetVincent Piguet
Jul 25, 2012·Proceedings of the National Academy of Sciences of the United States of America·Ushani S RajapaksaXiao-Ning Xu
Jul 28, 2012·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Chan-Juan ShenJian-Hua Wang
Jan 8, 2013·Retrovirology·Philip MwimanziTakamasa Ueno
Sep 18, 2013·Retrovirology·Jaclyn K MannZabrina L Brumme
Jun 9, 2014·Lancet·Gary MaartensSharon R Lewin
Jul 17, 2015·Journal of Virology·Mako ToyodaTakamasa Ueno
Sep 30, 2015·Nature·Yoshiko UsamiHeinrich G Göttlinger
Sep 30, 2015·Nature·Annachiara RosaMassimo Pizzato

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.